Response to r-HuEPO is dose-related and individualized. In case of an excessive erythropoietic response from an overdose of r-HuEPO, dosing should be stopped and phlebotomy can be considered. Supportive care should be provided for hypertensive or convulsive events that may be related to overdosing with r-HuEPO (see Warnings).